Cancer Stat Facts: Leukemia - Acute Lymphocytic Leukemia (ALL)
Statistics at a GlanceShow More
At a Glance
- Estimated New Cases in 2017 5,970
- Estimated Deaths in 2017 1,440
Number of New Cases and Deaths per 100,000: The number of new cases of acute lymphocytic leukemia was 1.7 per 100,000 men and women per year. The number of deaths was 0.4 per 100,000 men and women per year. These rates are age-adjusted and based on 2010-2014 cases and deaths.
Lifetime Risk of Developing Cancer: Approximately 0.1 percent of men and women will be diagnosed with acute lymphocytic leukemia at some point during their lifetime, based on 2012-2014 data.
Prevalence of This Cancer: In 2014, there were an estimated 81,837 people living with acute lymphocytic leukemia in the United States.
Survival StatisticsShow More
How Many People Survive 5 Years Or More after Being Diagnosed with Acute Lymphocytic Leukemia?
Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 18 2007-2013. Gray figures represent those who have died from acute lymphocytic leukemia. Green figures represent those who have survived 5 years or more.
Number of New Cases and DeathsShow More
How Common Is This Cancer?
|Common Types of Cancer||Estimated New
|1.||Breast Cancer (Female)||252,710||40,610|
|2.||Lung and Bronchus Cancer||222,500||155,870|
|5.||Melanoma of the Skin||87,110||9,730|
|8.||Kidney and Renal Pelvis Cancer||63,990||14,400|
|Acute Lymphocytic Leukemia||5,970||1,440|
Acute lymphocytic leukemia represents 0.4% of all new cancer cases in the U.S.
In 2017, it is estimated that there will be 5,970 new cases of acute lymphocytic leukemia and an estimated 1,440 people will die of this disease.
Who Gets This Cancer?
Acute lymphocytic leukemia is most common in children, adolescents, and young adults, or those 15 to 39 years of age. ALL is most common in Hispanics and Whites. The number of new cases of acute lymphocytic leukemia was 1.7 per 100,000 men and women per year based on 2010-2014 cases.
- All Races
- Asian /
- American Indian /
SEER 18 2010-2014, Age-Adjusted
Acute lymphocytic leukemia is most frequently diagnosed among people aged <20.
SEER 18 2010-2014, All Races, Both Sexes
Who Dies From This Cancer?
The number of deaths was 0.4 per 100,000 men and women per year based on 2010-2014 deaths.
- All Races
- Asian /
- American Indian /
U.S. 2010-2014, Age-Adjusted
The percent of acute lymphocytic leukemia deaths is highest among people aged 65-74.
U.S. 2010-2014, All Races, Both Sexes
Trends in RatesShow More
Changes Over Time
Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, rates for new acute lymphocytic leukemia cases have been rising on average 0.6% each year over the last 10 years. Death rates have been falling on average 1.1% each year over 2005-2014. 5-year survival trends are shown below the figure.
|5-Year Relative Survival||31.0%||49.0%||56.0%||55.8%||61.7%||62.6%||67.8%||68.8%|
SEER 9 Incidence & U.S. Mortality 1975-2014, All Races, Both Sexes. Rates are Age-Adjusted.
More About This CancerShow More
Cancer and the Blood
Leukemia is cancer that starts in the tissue that forms blood. Most blood cells develop from cells in the bone marrow called stem cells. In a person with leukemia, the bone marrow makes abnormal white blood cells. The abnormal cells are leukemia cells. Unlike normal blood cells, leukemia cells don't die when they should. They may crowd out normal white blood cells, red blood cells, and platelets. This makes it hard for normal blood cells to do their work. The four main types of leukemia are:
- Acute lymphoblastic leukemia (ALL)
- Acute myelogenous leukemia (AML)
- Chronic lymphocytic leukemia (CLL)
- Chronic myelogenous leukemia (CML)
Here are some resources for learning more about leukemia.
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:
Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Acute Lymphocytic Leukemia. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/alyl.html
These stat facts focus on population statistics that are based on the US population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.